long-acting interferon drug product company in Hepatitis and Cytokines
Home / Product Category / Drug Products / Molgramostim / Molgramostim

loading

Molgramostim Molgramostim

loading

Molgramostim

Strength:
Availability:
Quantity:
 
Trade Name: Topleucon
Generic Name: Molgramostim (Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor, rHuGM-CSF)
 
Product Description

Brief Introduction:

  • National Medical Insurance, Category B;

  • Launched in 1997,

  • The first China-made Molgramostim in market,

  • National standard bulk supplier of Molgramostim,

  • As an important immunomodulator of tumor vaccines, Topleucon® has participated in international clinical research in Europe in recent years. The relevant research results have been published on international authoritative tumor research platforms such as American Society of Clinical Oncology (ASCO) Annual Meeting.


Indications:
1.Treatment and prevention of leukopenia caused by radiotherapy or chemotherapy,
2.Treatment of bone marrow hematopoietic dysfunction and myelodysplastic syndrome,
3.Prevention of potential infection complications caused by leukopenia,
4.Accelerating recovery of neutrophils caused by infection
For details, please refer to Instructions.


Academic progress


Research Progress: Treatment of TG01/GM-CSF and adjuvant gemcitabine in patients with pancreatic cancer significantly improved survival rate, which indicates safety and efficiency

2020-03-16

Research progress: Combination of GM-CSF and radiotherapy can induce much stronger immune response

2020-03-16

Research progress: rHuGM-CSF helps to combat serious infections by improving the host immunity

2020-03-16

Research progress: Regimen CAGM shows better effect than CAG on treatment of M4/M5 leucocythemia

2020-03-16

Research progress: Long-lasting follow-up of 15 years shows good efficacy and safety of GM-CSF

2020-03-16

Animal experiment: GM-CSF effectively suppress tumor growth in mouse cell

2020-03-16

Research progress: GM-CSF can effectively prevent post-transplant fungal infections, reduce infections, reduce infection-related mortality and improve survival

2020-03-16

Research progress: Local radiotherapy plus GM-CSF can elicit abscopal response in metastatic solid tumours and improve overall survival

2020-03-16

Research progress: Combination of GM-CSF and immune checkpoint inhibitor, ipilimumab, can improve efficacy and reduce toxicity

2020-03-16

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button
Previous: 
Next: 

Related Products

Related News

content is empty!

Facebook
Twitter
LinkedIn
Instagram

WELCOME

Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Leave a Message
Get In Touch